Continuing Education Instructions and Disclosure Information:

Contact hours available until 10/31/2024.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (faculty, planners, reviewers, authors):
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for nursing continuing professional development credit by Michele Boyd, MSN, RN, NPD-BC, SUNA Education Director.

Learning Outcome:
After completing this education activity, the learner will be able to discuss how the use of intraurethral lidocaine during UDS may be considered a reasonable alternative to aqueous gel to reduce patient discomfort.

Joseph I. Schaffer MD, FACOG

Appearances